“Blinatumomab for Minimal Residual Disease Clearance in B-Acute Lymphoblastic Leukemia”. Annals of Medicine and Medical Sciences (March 1, 2026): 267–272. Accessed March 7, 2026. https://ammspub.com/index.php/amms/article/view/488.